Title : A new medical device II: Pebisut ® (C.P.Z.O.)
Abstract:
We present Pebisut® (Carbohydrate Polymer with Zinc Oxide) a Medical Device II, the result of our 23 years of research and the invitation of the National Institute of Health of the United States (N.I.A.I.D.) to obtain Grants R01 and R21 to continue with the same research line on: “Non-antibiotic products with Antibacterial properties”, non-toxic, for use in humans to be able to combat the Global problem of the new Pandemic of Multiple Bacterial Antibiotic-Resistance (A.M.R.), that has produced countless deaths and an enormous expense to global health systems that continues to increase. Pebisut® is protected by 7 patents (2 U.S.P.T.O., 2 Canada, 2 Mexico, 1 European Union) and supported by 13 scientific publications. Likewise, the G7 International Meeting committee at Cornwall invited us to review several publications on A.M.R. presentations for that meeting “The G7 Summit 2021: Time for our world leaders to step up to the challenge of Anti-Microbial Resistance Access Microbiology”, in Cornwall, Uk, 11-13 June 2021.
Pebisut® does have potent antimicrobial properties to Multi-resistant bacteria such as Methicillin-resistant Staphylococcus A., Pseudomonas A., Enterococcus, etc., without any undesirable effects after more than 40,000 applications in large Medical Institutions.
